baber/WOPTO huggingface dataset:
Patent NZ-527849-A (NZ)
Title: Post-partum mammalian placenta, its use and placental stem cells therefrom
Inventor: HARIRI ROBERT J
IPC: A61K35/12
Filed: 2002-02-13
Abstract: Described is an isolated, bloodless mammalian placenta that has been exsanguinated and perfused under sterile conditions, wherein the solution used to perfuse the placenta contains an antimicrobial agent, an anticoagulant solution or growth factors. Also described is the exsanguinated and perfused placenta which is incubated under conditions to allow for the production of embryonic-like stem cells and other multipotent stem cells, a method of culturing a mammalian placenta after expulsion from the uterus, an isolated multipotent or pluripotent stem cell having at least the following characteristics: CD10+, CD29+, CD34-, CD44+, CD45-, CD45+, CD54+, CD90+, SH2+, SH3+, SH4+, SSEA3-, SSEA4-, OCT-4+ and ABC-p+ and the use of the placental stem cell for the manufacture of a composition for transplanting stem cells or treating disease in a patient.
Patent NZ-528144-A (NZ)
Title: Compound having a high conductivity for electrons; electrode for an electrochemical cell which comprises this compound, method for preparing an electrode and electrochemical cell
Inventor: VAN HEUVELN FREDERIK HENDRIK
IPC: H01G9/00
Filed: 2002-03-11
Abstract: A compound ABCO(x- delta)Hal(y- zeta) with a potassium nickel fluorite structure that has a high conductivity for electrons is disclosed, where x + y = 4, and delta and zeta lie between 0.7 and + 0.7, and wherein A comprises at least one metal selected from the group consisting of Na, K, Ca, Ba, La, Pr, Sr, Ce, Nb, Pb, Nd, Sm, and Gd, and wherein B comprises at least one metal selected from the same group, and wherein C comprises at least one metal selected from the group consisting of Cu, Mg, Ti, V, Cr, Mn, Fe, Co, Nb, Mo, W and Zr and/or a metal selected from the group consisting of Pt, Ru, Ir, Rh, Pd and Ni, where A and B are not identical and wherein A and C are not both Nb and wherein Hal comprises at least one halogen atom selected from the group consisting of F, Cl, Br and I. Also disclosed is an electrode for an electrochemical cell; a method for preparing an electrode of this type and an electrochemical cell formed with an electrode of this type.
Patent NZ-531918-A (NZ)
Title: Needle assembly including sliding lockable needle sheath
Inventor: POPOVSKY FRANK
IPC: A61M5/28
Filed: 2003-05-22
Abstract: Disclosed is a needle assembly which includes an elongated needle mount 10, a needle 12, and a sheath 14. Portion 16 of needle mount 10 is adapted to fit onto the forward end of a syringe. Sheath 14 is mounted on needle mount 10 for reciprocal axial movement between a forward position where the sheath covers the needle 12 and a rearward position where the needle 12 is exposed. Members 30 at the rear of the sheath engage a portion 18 of the mount when the sheath is in a rearward injecting position. After injection the sheath 14 is axially rotated through 90 degrees relative to the needle mount 10 to disengage the members 30 from the ramps 24. The sheath 14 then automatically slides under the action of a compression spring to the forward position so that the resilient members 30 engage the second ramps 26, rendering the needle 12 safe.
Patent NZ-533732-A (NZ)
Title: Antibiotics GE 81112 factors A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof
Inventor: SELVA ENRICO
IPC: C12R1/465
Filed: 2002-10-04
Abstract: Antibiotic GE 81112 Factors A, B and B1 and mixtures thereof having particular characteristics, obtainable by cultivating Streptomyces sp. DSMZ 14386.
Patent NZ-537405-A (NZ)
Title: Acutumine and acutumine compounds, synthesis and use for treating neurodegenerative diseases and cerebral diseases of aging
Inventor: QIN GUO-WEI
IPC: A61K31/47
Filed: 2003-06-16
Abstract: Acutumine compounds of formula (I) are described wherein: R1 and R2 are hydrogen or together form an additional bond R3 is hydrogen or an alkoxy group R4 is hydrogen, or a hydroxy, alkoxy, alkylcarbonyloxy or arylcarbonyloxy group R5 is hydrogen or a halogen group R6 is hydrogen or an alkyl, alkylcarbonyl or aroyl group R7 and R10 are alkoxy groups R8 and R9 together form an additional bond or R8 and R13 together form a sulphide bridge and in the case R9 and R10 together form an oxo group and R14 is a chlorine group R11 is a hydroxy or alkoxy group R12 is hydrogen or R11 and R12 together form an oxo, oxime, or O-alkyl-oxime group R13 and R14 are hydrogen or together form an oxo group. Acutumine and acutumine compounds are useful in pharmaceutical compositions for the treatment of deficiencies of memory associated with cerebral ageing and neurodegenerative diseases, such as AlzheimerÆs disease, ParkinsonÆs disease. PickÆs disease, KorsakoffÆs disease and frontal lobe and subcortical dementias.
Patent NZ-538876-A (NZ)
Title: Dispensing assembly for preparing beverages from soluble products
Inventor: MAJER DOGLIONI LUCA
IPC: A47J31/06
Filed: 2002-10-03
Abstract: A method and a group are described for the preparation of a beverage from soluble products contained in a disposable cartridge (1), based on the regulation of the dispensing of the beverage in such way that the soluble product is delivered in suspension for at least 75% of the total dispensing time. According to one embodiment said group comprises one delivery port between the wall of the piercing member (7) and the edge (5a) of the outlet opening of the cartridge (1).
Patent NZ-546187-A (NZ)
Title: Compact jacquard selecting card using piezoelectric elements
Inventor: BARTH BERNARD
IPC: H01L41/08
Filed: 2004-09-20
Abstract: A selection device for a Jacquard machine is disclosed. The selection device comprises a parallel array of evenly spaced piezoelectric actuated flexure elements, lying in a plane, and a holding bar connecting a second end of each flexure element in the array lying in the same plane. Each flexure element in the array has a corresponding hook element connected to a first end thereof. An axial rod is parallel to the holding bar and passes through an axis hole in each hook element to provide a common axis for each hook element to pivot. Each hook element is independently positioned by actuating the piezoelectric in the corresponding flexure element, thereby causing the flexure element to bend out of the plane and forcing the connected hook element to pivot about the common axis.
Patent NZ-554216-A (NZ)
Title: Temporary dental prosthesis
Inventor: LAST-POLLAK MORDEHAI
IPC: A61C13/107
Filed: 2005-09-15
Abstract: A temporary resilient, deformable tooth shaped prosthesis 15 for use during the osseointegration process of an installed dental implant comprises an external surface and an interface for mounting on the implant, with the prosthesis 15 configured to substantially absorb and minimise the transmission of externally applied loads to the implant. The prosthesis body 15 is reversibly deformed on the application of an external load 15.
Patent NZ-555661-A (NZ)
Title: Triazolophthalazines as PDE2-inhibitors
Inventor: SCHMIDT BEATE
IPC: A61K31/5025
Filed: 2006-01-04
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. The compounds are anilino-substituted triazolophthalazine derivatives which are PDE2-inhibitors useful in the treatment of respiratory diseases.
Patent NZ-569562-A (NZ)
Title: Placental stem cell populations, CD200
Inventor: ABRAMSON SASCHA DAWN
IPC: A61K35/644
Filed: 2006-12-28
Abstract: Provided is a method of producing a cell population comprising isolating from other cells placental stem cells that adhere to a substrate, and determining that said placental stem cells express CD200; wherein said isolated placental stem cells constitute said cell population, and wherein said placental stem cells are not totipotent stem cells or trophoblasts. The stem cells can differentiate to chondrocytes or osteogenic cells.
Patent NZ-574507-A (NZ)
Title: Multilateration apparatus
Inventor: BAKER ADAM ALEXANDER
IPC: G01S5/02
Filed: 2009-01-29
Abstract: A multilateration system controller comprises time of arrival correlator for performing a time of arrival correlation using a time of arrival window based on receiver location applying the window to received synchronised time of arrival data to determine which data has a low and which data has a high probability of originating from a single aircraft and passing at least the data with a high probability to a multilateration processor which performs a multilateration to determine the position of the aircraft. The time arrival window comprises the time difference that is experienced for receipt of a signal by receivers in a multilateration system.
Patent NZ-575443-A (NZ)
Title: Telephony services for programmable multimedia controller
Inventor: SILVA MICHAEL C
IPC: H04M1/247
Filed: 2007-09-12
Abstract: An integrated multimedia, entertainment, communications and control system capable of providing programmable telephony services comprises a programmable multimedia controller having at least one interface for communicating with a public switched telephone network, a private network or an internet and a remote control having location awareness functionality and user profile awareness enabling the programmable multimedia controller to place video calls in a desired zone based on programmable services supported in the zone. The programmable multimedia controller is further configured to include one or more storage devices coupled with one or more general purpose computers, to provide expanded storage capacity, for storing digital media and being capable of controlling, switching data between and/or interoperating with a variety of electronic devices; at least one touchscreen interfaced with the programmable multimedia controller, the touchscreen configurable to function as a virtual telephone and user-operable to initiate outgoing telephone calls and to answer incoming telephone calls, and the touchscreen being further configurable to include displaying text and graphics overlaid on another video signal. The programmable multimedia controller is further configured for switching within zones. The variety of electronic devices can be audio, video, telephony, data, security, photo-driven, relay-driven, and/or other types of electronic devices.
Patent NZ-575749-A (NZ)
Title: Mixtures comprising strobilurins and ethylene modulators
Inventor: HARDEN JOHN S
IPC: A01N43/653
Filed: 2004-11-05
Abstract: The disclosure relates to mixtures comprising a) a compound of the formula (I) wherein, Xm, Q and A are as defined in the specification and b) one or more ethylene modulators (II) selected from group consisting of inhibitors of ethylene biosynthesis which inhibit the conversion of S-adenosyl-L-methionine to 1-aminocyclopropane-1-carboxylic acid (ACC), inhibitors of ethylene biosynthesis which block the conversion of ACC into ethylene, or inhibitors of ethylene action. Also disclosed are compositions comprising them and to their use of controlling fungal infection in legumes. (62) Divided Out of 546939
Patent NZ-585517-A (NZ)
Title: 5-[3-(2-Alkyl-cyclopentyl)-propyl]thiophene-2-carboxylic acid derivatives as prostaglandin analogues, and pharmaceutical uses thereof
Inventor: DONDE YARIV
IPC: A61P27/06
Filed: 2008-11-05
Abstract: Disclosed are 5-[3-(2-alkyl-cyclopentyl)-propyl]thiophene-2-carboxylic acid derivatives as represented by the general formula, wherein: R is H, or alkyl or phenyl which are optionally substituted with 0 to 2 hydroxy groups; Y is chloro, fluoro, cyano, or trifluoromethyl; and X consists of: a linear alkyl or alkenyl group which is optionally substituted with 0 to 3 hydroxyl groups. Representative compounds include 5-[3-((1R,2R,3R,5R)-5-chloro-3-hydroxy-2-pentyl-cyclopentyl)-propyl]thiophene-2-carboxylic acid; 5 -[3-((1R,2R,3R,5R)-5 -chloro-2-hexyl-3-hydroxy-cyclopentyl)-propyl]thiophene-2-carboxylic acid; 5-[3-((1R,2R,3R,5R)-5-chloro-2-heptyl-3-hydroxy-cyclopentyl)-propyl]thiophene-2-carboxylic acid; 5-[3-((1R,2R,3R,5R)-5-chloro-3-hydroxy-2-octyl-cyclopentyl)-propyl]thiophene-2-carboxylic acid; 5-[3-((1R,2R,3R,5R)-5-chloro-3-hydroxy-2-nonyl-cyclopentyl)-propyl]thiophene-2-carboxylic acid; 5-{ 3-[(1R,2R,3R,5R)-5-chloro-3-hydroxy-2-(8-hydroxy-oct-1-enyl)cyclopentyl]-propyl} -thiophene-2-carboxylic acid; 5-[3-((1R,2R,3R,5R)-5-chloro-3-hydroxy-2-pent-1-enyl-cyclopentyl)-propyl]thiophene-2-carboxylic acid; 5-[3-((1R,2R,3R,5R)-5-chloro-2-hept-1-enyl-3-hydroxy-cyclopentyl)-propyl]thiophene-2-carboxylic acid; 5-{ 3-[(1R,2R,3R,5R)-5-chloro-3-hydroxy-2-((E)-(R)-3-hydroxy-oct-1-enyl)-cyclopentyl]-propyl} -thiophene-2-carboxylic acid; and 5-{ 3-[(1R,2R,3R,5R)-5-chloro-3-hydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-propyl} -thiophene-2-carboxylic acid. Further disclosed is an ophthalmically acceptable liquid which comprising a compound as defined above and an ophthalmically acceptable excipient for the treatment of glaucoma.
Patent NZ-585980-A (NZ)
Title: Isoquinoline modulators of atp-binding cassette transporters
Inventor: HADIDA RUAH SARA
IPC: A61P11/00
Filed: 2008-11-14
Abstract: The disclosure relates to a substituted isoquinoline derivative of the structural formula shown herein and pharmaceutically acceptable salt thereof, which is useful as a modulator of ATP-Binding Cassette ("ABC") transporter activity, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). Said substituted isoquinoline compound may be suitable for treating ABC transporter mediated diseases selected from cystic fibrosis, asthma, smoke induced COPD, chronic bronchitis, rhinosinusitis, constipation, pancreatitis, pancreatic insufficiency, male infertility caused by congenital bilateral absence of the vas deferens, mild pulmonary disease, idiopathic pancreatitis, allergic bronchopulmonary aspergillosis, liver disease, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis deficiencies, lipid processing deficiencies, lysosomal storage diseases, Crigler-Najjar type II, polyendocrinopathy/hyperinsulemia, Diabetes mellitus, Laron dwarfism, myleoperoxidase deficiency, primary hypoparathyroidism, melanoma, glycanosis CDG type 1, congenital hyperthyroidism, osteogenesis imperfecta, hereditary hypofibrinogenemia, ACT deficiency, Diabetes insipidus, neurophyseal DI, neprogenic DI, Charcot-Marie Tooth syndrome, Perlizaeus-Merzbacher disease, neurodegenerative diseases several polyglutamine neurological disorders as well as spongiform encephalopathies, COPD, dry-eye disease and Sjogren's disease.
Patent NZ-591712-A (NZ)
Title: Imidazopyridazinecarbonitriles useful as kinase inhibitors
Inventor: FINK BRIAN
IPC: A61K31/4188
Filed: 2009-10-08
Abstract: Disclosed is a substituted imidazo[1,2-b]pyridazine compound of formula (I) where the substituents are as disclosed in the specification and examples of compounds are: N-(5-((3-Cyano-8-(cyclopropylamino)imidazo[1,2-b]pyridazin-6-yl)amino)-2-methylphenyl)acetamide; N-(6-(3-Cyano-8-(cyclopropylamino)imidazo[1,2-b]pyridazin-6-ylamino)pyridin-2-yl)acetamide and N-(3-(3-Cyano-8-(cyclopropylamino)imidazo[1,2-b]pyridazin-6-ylamino)phenyl)methanesulfonamide. Also disclosed is pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula(I) in the manufacture of a medicament for treating cancer, psoriasis or rheumatoid arthritis.
Patent NZ-593942-A (NZ)
Title: Self-adhesive radiant heating underlayment
Inventor: HOPKINS JOHN
IPC: B32B7/04
Filed: 2010-01-08
Abstract: 593942 Disclosed is a heated flooring underlay. The underlay comprises a flexible heating element (120), a lower waterproof membrane (110) and an upper waterproof membrane (140). The top surface of the lower waterproof membrane is attached to the bottom surface of the flexible heating element. An edge of the lower waterproof membrane extends beyond the edge of the flexible heating element, defining a lower sealing flap. The bottom surface of the upper waterproof membrane is attached to the top surface of the flexible heating element. An edge of the upper waterproof membrane extends beyond the edge of the flexible heating element, defining an upper sealing flap. Upper and lower sealing flaps both respectively include a peel away release sheet (118, 148). During installation of the underlay to a desired surface these release sheets prevent the upper and lower membranes from adhering together. Once the flexible heating element is connected to a source of electricity and/or an adjacent heating element the peel away release sheets may be removed, thereby allowing the upper and lower sealing flaps to adhere together (see figure 7B) and providing a waterproof enclosure for the flexible heating element.
Patent NZ-594725-A (NZ)
Title: Verifiable device assisted service usage monitoring with reporting, synchronization, and notification
Inventor: RALEIGH GREGORY G
IPC: H04W4/24
Filed: 2010-01-15
Abstract: 594725 Disclosed is a wireless end-user device (100). The device (100) includes one or more wireless modems for enabling the end-user device (100) to communicate over at least a first wireless access network (1610). Memory within the device (100) is configured to store a first service policy to be applied when the wireless end-user device (100) communicates or attempts to communicate over the first wireless access network (1610). The first service policy is associated with a first service activity that has a data communication associated with a particular application of a plurality of applications on the wireless end-user device (100). The device (100) also includes one or more processors (115) configured to determine that a traffic flow is associated with the first service activity such that the traffic flow has one or more related data transfers or attempted data transfers. A flow tag is assigned to the traffic flow and includes a traffic flow identifier. The identifier is configured to assist in preserving the association of the traffic flow with the first service activity when the traffic flow is processed by one or more device functions that operate on the traffic flow. A first wireless access network service usage or attempted service usage associated with the flow tag is also monitored. The determining, assigning, and monitoring as stated above can occur in any order, and after determining that the traffic flow is associated with the first service activity, the first service policy is applied to the first wireless access network service usage or attempted service usage.
Patent NZ-602387-A (NZ)
Title: Abrasive tool and a method for finishing complex shapes in workpieces
Inventor: LAMOUREUX MARC A
IPC: B24D7/18
Filed: 2011-08-05
Abstract: An abrasive tool includes a bonded abrasive body having abrasive grains dispersed throughout a three dimensional volume of a bonding material. The bonded abrasive body comprises a complex shape, that is, a re-entrant shape, having a form depth (FD) of at least about 0.3, and an overhang ratio of at least about 1.3. The complex shape includes a first radial flange extending from the bonded abrasive body at a first axial position. The abrasive tool can be used to finish complex shapes in work-pieces. The geometrical definitions of “form depth” and “overhang ratio” are disclosed in the specification.
Patent NZ-602720-A (NZ)
Title: Humanized il-25 antibodies
Inventor: TAUDTE SUSANN
IPC: C07K16/24
Filed: 2011-03-30
Abstract: Discloses an isolated target binding member that binds to IL-25 comprising light chain CDR sequences of: SASQGISNYLN, YTSSLHS, QQYLAFPYTF and heavy chain CDR sequences of: GYTMN, LINPYNGGTSYNQNFKG, EDYDGYLFAMDY; and use in treating asthma or inflammatory bowel disease.
Patent NZ-603396-A (NZ)
Title: System and process for equalization of pressure of a process flow stream across a valve
Inventor: BATHURST CHRISTOPHER FRANCIS
IPC: F17D1/14
Filed: 2011-05-05
Abstract: A process for equalizing pressure of a flow stream across a valve, the process comprises providing a first process valve 19 having a flow stream of a process fluid with a first pressure on a pump side and a second pressure on a second side of the process valve 19, providing a pump 17 upstream from the pump side of the first process valve, where the pump comprises a floating piston 18 within a housing, one side of the floating piston 18 being in fluid connection with a non-abrasive fluid, providing a slave cylinder C containing a reciprocating piston 94 having one side in fluid connection with the flow stream of the process fluid downstream from the second side of the first process valve 19, the other side of the reciprocating piston 94 being in fluid connection with a first non-abrasive fluid line, arranging a needle valve 92 along the first non-abrasive fluid line between the pump 17 and the slave cylinder C, and actuating the needle valve 92 to permit flow of the non-abrasive fluid between the slave cylinder C and the pump 17 thereby equalizing the first pressure with the second pressure.
Patent NZ-615297-A (NZ)
Title: A powder mix and a method for producing a building panel
Inventor: PERSSON HANS
IPC: E04B5/00
Filed: 2012-04-11
Abstract: Dislcosed herein is a method for producing a building panel comprising the steps of: - applying a powder mix layer (2) on a substrate (1), the powder mix layer comprising wood fibres and a binder; - adjusting a weight loss on cure of the powder mix layer by a step of applying a stabilisation fluid (at 4), or a step of drying (5), or a combination thereof such that the powder mix layer obtains the weight loss on cure in a range of about 2 to about 7 wt-%; and - applying heat and pressure (6) to the powder mix layer when arranged on the substrate and curing the powder mix layer having the weight loss on cure in the range of about 2 to about 7 wt-%, and thereby obtaining a layer of the building panel formed by the powder mix layer.
Patent NZ-616201-A (NZ)
Title: Production of soluble protein solutions from soy (“s701”)
Inventor: LOGIE JAMES
IPC: A23L11/30
Filed: 2009-10-21
Abstract: Disclosed is a soy protein product having a protein content of at least 60 wt% (N x 6.25) d.b. which is substantially completely soluble in an aqueous medium at an acid pH of less than 4.4 and at a pH of 7.
Patent NZ-618950-A (NZ)
Title: Bioprocessing
Inventor: MEDOFF MARSHALL
IPC: C12N11/14
Filed: 2010-05-18
Abstract: Disclosed is a fermentation method comprising: (a) functionalising inorganic fibres by irradiating the fibres with ionising radiation and quenching the irradiated fibres; and (b) contacting a low molecular weight sugar with the functionalised inorganic fibres and a fermenting microorganism immobilised on the fibres, within a medium, for a period of time and under suitable fermentation conditions to convert the low molecular weight sugar to a fermentation product, whereby the immobilisation occurs as a result of interaction between functional groups on the functionalised fibres and functional groups on the microorganism.
Patent NZ-623846-A (NZ)
Title: Rod-like hepatitis c virus inhibitors containing the fragment { 2-[4-(bi phenyl-4-yl) -1h-imidazo-2-yl] pyrrolidine-1-carbonlymethyl} amine
Inventor: LONG DANIEL D
IPC: C07D491/113
Filed: 2012-11-02
Abstract: Disclosed herein are compounds of formula (I): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof. The compounds are inhibitors of replication of the hepatitis C virus and are intended for use for treating hepatitis C. Also disclosed are pharmaceutical compositions comprising the compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds. Examples of the compounds of formula I include ((S)-1-{ (2S,4S)-2-[4-(5’-chloro-4’-{ [6-((2R,5S)-2,5-dimethyl-4-methylcarbamoyl-piperazin-1-yl)-pyridine-3-carbonyl]-amino} -2’-trifluoromethoxybiphenyl-4-yl)-1H-imidazol-2-yl]-4-methyl-pyrrolidine-1-carbonyl} -2-methylpropyl)-carbamic acid methyl ester and Methyl (S)-2-((2S,4S)-2-(4-(5’-chloro-4’-(6-((R)-2-methyl-4-pivaloylpiperazin-1-yl)pyridin-3-ylcarbamoyl)-2’-(trifluoromethoxy)biphenyl-4-yl)1H-imidazol-2-yl)-4-methylpyrrolidin-1-yl)-1-((2S,6S)-2,6-dimethyltetrahydro-2H-pyran-4-yl)-2-oxoethylcarbamate.